Avalyn Pharma Inc. Share Price

Avalyn Pharma Inc. Share Price

NASDAQ: AVLN
$25.66
-$0.05 (-0.21%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Avalyn Pharma Inc. Stock Performance

Open
$25.46
Prev. Close
$25.71
Circuit Range
N/A
Day Range
$25.11 - $26.08
Year Range
$22.89 - $39.95
Volume
24,085
Average Traded
$25.58

Avalyn Pharma Inc. Share Price Today

As of 31 October 2026, Avalyn Pharma Inc.'s share price is $25.66. The stock opened at $25.46, compared to its previous close of $25.71. During today's trading session, Avalyn Pharma Inc.'s share price traded between $25.11 and $26.08, with an average price of $25.59. Over the past 52 weeks, the stock has recorded a high of $39.95 and a low of $22.89. In terms of performance, Avalyn Pharma Inc.'s share price has declined by 11.79% over the last six months and is down 11.79% on a year-on-year basis.

Avalyn Pharma Inc. Share Price Chart

Line chart of the Avalyn Pharma Inc. price trend over the selected period. The price fell overall, ranging from 24.90 to 26.14, ending at 25.66.
$25.11$26.08
L
Show Current Price
H

Avalyn Pharma Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Avalyn Pharma Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2026
Revenue$0.00
Net Profit-$28.94
Net Profit MarginN/A
Income ChangeN/A

About Avalyn Pharma Inc.

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Avalyn Pharma Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$27.75
$25.63
-10.29%
Sep 2026
$35.39
$28.57
-21.76%
Aug 2026
$28.02
$36.51
+27.06%
Jul 2026
$32.53
$28.73
-12.61%
Jun 2026
$28.00
$32.88
+14.84%
May 2026
$27.73
$28.63
-1.58%
Apr 2026
$26.00
$29.09
N/A

AVLN Share Price FAQs